SCHEMBL9887917

SCHEMBL9887917

Fc1cccc(Cc2nnc(-c3c[nH]c4ncc(Br)cc34)o2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 6/20 0.52
▸ CDC7 O00311 5/20 0.52
▸ CCNE1 P24864 5/20 0.52
▸ DBF4 Q9UBU7 5/20 0.52
▸ DYRK1A Q13627 4/20 0.46
▸ CDK1 P06493 2/20 0.46
▸ PLK4 O00444 1/20 0.46
▸ AURKA O14965 1/20 0.46
▸ JAK2 O60674 1/20 0.46
▸ ROCK2 O75116 1/20 0.46
▸ PRKD3 O94806 1/20 0.46
▸ MAP4K4 O95819 1/20 0.46
▸ PRKCG P05129 1/20 0.46
▸ INSR P06213 1/20 0.46
▸ FES P07332 1/20 0.46
▸ IGF1R P08069 1/20 0.46
▸ ROS1 P08922 1/20 0.46
▸ FGFR1 P11362 1/20 0.46
▸ PHKG2 P15735 1/20 0.46
▸ FER P16591 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15257736 0.88 CDK2 (0.46) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL9277787 0.81 ALK (0.65) ALKMETPDPK1
SCHEMBL9280778 0.76 CLK1 (0.46) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL9888186 0.71 ALK (0.63) ALKPDPK1
SCHEMBL31326342 0.70 HTR6 (0.52) DYRK1ACLK1SNCA
SCHEMBL7955873 0.70 CDK2 (0.55) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL15257725 0.68 PLK4 (0.55) CDK2DYRK1ACDK1PLK4AURKA
SCHEMBL7946423 0.68 CDC7 (1.00) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL9888177 0.67 ALK (0.59) ALKPDPK1
SCHEMBL14335342 0.67 CDC7 (0.65) CDK2CDC7CCNE1DBF4ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130245355-A1 3-HETARYL-SUBSTITUTED PYRROLO[2,3 B]PYRIDINE DERIVATIVES AS PDK1 INHIBITORS MERCK PATENT GMBH (DE) 2013-09-19 — — US disclosed
US-20130245355-A1 3-HETARYL-SUBSTITUTED PYRROLO[2,3 B]PYRIDINE DERIVATIVES AS PDK1 INHIBITORS MERCK PATENT GMBH (DE) 2013-09-19 — — US disclosed
CN-103228657-A 3-heteroaryl-substituted pyrrolo [2,3-b ] pyridine derivatives as PDK1 inhibitors MERCK PATENT GMBH 2013-07-31 — — CN disclosed
WO-2012072200-A1 3-HETARYL-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS PDK1 INHIBITORS MERCK PATENT GMBH (DE) 2012-06-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245355-A1 3-HETARYL-SUBSTITUTED PYRROLO[2,3 B]PYRIDINE DERIVATIVES AS PDK1 INHIBITORS PDK1, PDK2, PDK3 CDK2 43/4885CDC7 383/4885CCNE1 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback